As of February 2, 2026, Hyloris Pharmaceuticals SA has provided updated information regarding its total number of voting rights and shares. The data pertains to the company’s stock listed on Euronext Brussels under the ticker BE0974363955.
This update reflects the current denominator used for calculating voting rights, which is essential for shareholders and market participants monitoring ownership and control within the company.
**Why this matters**
The total number of voting rights and shares determines the basis for shareholder voting power and influences decisions made at corporate meetings. Accurate and timely disclosure ensures transparency and helps maintain fair market practices.
Source: NewsData